| 15.20 Data as of Jun 19 |  -0.20 / -1.30%Today’s Change | 4.36 Today|||52-Week Range 16.48 | +126.53% Year-to-Date |
| Cramer's 'Mad Money' Recap: Time to Change Your Strategy Jun 19 / TheStreet.com | Good And Bad Breast Cancer Drugs Jun 14 / MotleyFool.com |
| A Trio of Cancer Immunotherapy Innovators Jun 14 / MotleyFool.com | A Promising Platform for Cancer Immunotherapy Jun 10 / MotleyFool.com |
| Previous close | 15.40 |
| Today’s open | 15.48 |
| Day’s range | -- - -- |
| Volume | 1,140,524 |
| Average volume (3 months) | 1,441,071 |
| Market cap | $1.2B |
| Dividend yield | -- |
| Earnings growth (last year) | +9.73% |
| Earnings growth (this year) | +8.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +20.91% |
| P/E ratio | NM |
| Price/Sales | 34.57 |
| Price/Book | 10.35 |
| Today’s change | Today’s % change | |
|---|---|---|
| MGMistras Group Inc | +0.05 | +0.23% |
| FCSCFibrocell Science In... | +0.56 | +8.76% |
| UBICUBIC Inc | +0.48 | +6.98% |
| RPBIFResponse Biomedical ... | 0.00 | 0.00% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $11.2M |
| Annual profit (last year) | -$59.1M |
| Net profit margin | -527.79% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Anthony S. Marucci, MBA |
CFO, Secretary, Treasurer & Senior Vice President Avery W. Catlin, MBA, CPA |
Corporate headquarters Needham, Massachusetts |
.
